Company: PRGO
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001585364-25-000156
Chunk: 110

Company: PERRIGO Co plc
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 7
Chunk 110
---
2025, we reclassified $98.1 million net book value of associated intangible assets to Current assets held for sale (refer to Note 4).During the nine months ended September 27, 2025, we identified an impairment indicator related to our Prevacid® definite-lived intangible asset in our CSCA segment. The indicator related to expected long-term decline in contribution margin. We determined a fair value assessment of the asset was required. The assessment resulted in an asset impairment of $1.5 million (refer to Note 10).

16

Perrigo Company plc - Item 1Note 9

We recorded amortization expense of $55.8 million and $167.2 million for the three and nine months ended September 27, 2025, respectively, and $57.5 million and $173.4 million for the three and nine months ended September 28, 2024, respectively.

NOTE 10 - FAIR VALUE MEASUREMENTS 

The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):September 27, 2025December 31, 2024Measured at fair value on a recurring basis:Level 1Level 2Level 3Level 1Level 2Level 3Assets:Foreign currency forward contracts$— $2.6 $— $— $5.5 $— Cross-currency swaps— — — — 14.2 — Interest rate swap agreements— 2.4 — — 9.3 — Total assets$— $5.0 $— $— $29.0 $— Liabilities:Foreign currency forward contracts$— $14.3 $— $— $5.6 $— Cross-currency swaps— 262.0 — — 46.8 — Interest rate swap agreements— 34.2 — — 22.6 — Total liabilities$— $310.5 $— $— $75.0 $— Measured at fair value on a non-recurring basis:Assets:Contingent consideration(1) $— $— $— $— $— $34.5 Definite-lived intangible assets(2)— — 5.5 —